DCB at AACR 2026

April 21, 2026 (10:15 - 11:15 AM)
NCI/NIH Consortia Initiative: Metabolic Dysregulation and Cancer Risk Program—A Transdisciplinary Approach to Obesity-Associated Cancers (NIH07)
This session provided an overview of the Metabolic Dysregulation and Cancer Risk Program (MeDOC) consortium, including the scientific investigations, collaborative efforts, and resources available through the program. 

Additional information about this initiative can be found at the MeDOC website. 

April 21, 2026 (4:00 - 5:00 PM)
NCI Funding of Extramural Cancer Biology Research (NIH10)
This session provided an opportunity for early-stage and established investigators to interact directly with NCI staff, including the DCB Director Dr. Dan Gallahan. Topics included the NCI grants system, communicating with a program director, considerations for a successful grant application, as well as funding opportunities and highlighted topics related to cancer biology.

Additional information can be found in the following presentation slides:

• Overview: NCI Funding of Extramural Cancer Biology Research
• Introduction to the NCI Grants System
• Communicating with Your NCI Program Director: It’s a Two-Way Street
• Considerations for a Successful NCI Grant Application
• DCB Funding Opportunities and NIH Highlighted Topics 

April 19, 2026 (4:00 - 4:30 PM)
Human Tumor Atlas Network (HTAN) Resources
Drs. Sean Hanlon & Sharmistha Ghosh-Janjigian (DCB Program Directors) and Dr. Indu Kohaar (an NCI Division of Cancer Prevention Program Director) shared HTAN data and resources that are available to the community. 

April 21, 2026 (10:00 - 10:30 AM)
The Human Cancer Models Initiative (HCMI)
Dr. Justin Benavidez (a DCB Program Directors) presented HCMI models and resources that are available to researchers.

• Information about DCB
• NCI Funding Policy Related to Cancer Biology

For additional information about DCB activities at AACR 2026, please contact Dr. Claire McCarthy.